代謝體學全球市場規模、佔有率、趨勢和成長分析報告（2026-2034）

全球代謝體學市場預計將從2025年的39.2億美元成長至2034年的112.9億美元，2026年至2034年的複合年成長率（CAGR）為12.46%。全球代謝體學市場正經歷快速成長，這主要得益於人們對個人化醫療和先進疾病研究的日益關注。代謝體學研究生物系統中的小分子，幫助科學家了解疾病機制並辨識生物標記。對藥物研發和生物技術投資的增加正在推動對代謝體學技術的需求。

此外，質譜和核磁共振（NMR）技術的進步也推動了市場成長。這些工具能夠對複雜的生物樣本進行精確分析，從而支持藥物研發和臨床診斷。人們對疾病早期檢測和精準醫療的日益重視，正在加速代謝體學在研究和醫療機構中的應用。

未來，人工智慧（AI）和巨量資料分析的融合有望提升數據解讀和研究成果。代謝組學在營養學、毒理學和環境研究等領域的應用拓展將進一步擴大市場規模。隨著醫療保健領域持續創新和投資增加，代謝體學市場預計在未來幾年將保持強勁的成長動能。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為特定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別未來預期趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球代謝體學市場：依產品與服務分類

• 市場分析、洞察與預測
• 代謝體學學設備
• 代謝體學和生物資訊學工具及服務

第5章 全球代謝體學市場：依應用領域分類

• 市場分析、洞察與預測
• 生物標記的發現
• 藥物發現
• 毒性測試
• 營養基因體學
• 功能基因體學
• 個人化醫療
• 其他用途

第6章：全球代謝體學市場：依適應症分類

• 市場分析、洞察與預測
• 癌症
• 心血管疾病
• 神經病變
• 先天性代謝缺陷
• 其他改編

第7章 全球代謝體學市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 中國
  • 日本
  • 韓國
  • 印度
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific
  • Danaher
  • Agilent Technologies
  • Bruker
  • Shimadzu
  • Waters Corporation
  • QIAGEN
  • Revvity
  • Biocrates Life Sciences
  • Metabolon
  • Creative Proteomics
  • Nightingale Health
  • Human Metabolome Technologies
  • Chenomx
  • LECO
  • JEOL
  • SCIEX
  • Numares
  • OWL Metabolomics
  • Xcelris Labs

The global metabolomics market size is expected to reach USD 11.29 Billion in 2034 from USD 3.92 Billion in 2025, growing at a CAGR of 12.46% during 2026-2034.The Global Metabolomics Market is witnessing rapid growth due to rising interest in personalized medicine and advanced disease research. Metabolomics studies small molecules in biological systems, helping scientists understand disease mechanisms and identify biomarkers. Increasing investments in pharmaceutical research and biotechnology are fueling demand for metabolomics technologies.

The market is also driven by technological advancements in mass spectrometry and nuclear magnetic resonance techniques. These tools enable accurate analysis of complex biological samples, supporting drug discovery and clinical diagnostics. Growing focus on early disease detection and precision healthcare is encouraging the use of metabolomics in research laboratories and healthcare institutions.

Looking ahead, integration of artificial intelligence and big data analytics is expected to enhance data interpretation and research outcomes. Expanding applications in nutrition, toxicology, and environmental studies will further broaden market scope. With continuous innovation and rising healthcare investments, the metabolomics market is expected to maintain strong growth momentum in the coming years.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product and Services

• Metabolomics Instruments
• Metabolomics Bioinformatics Tools and Services

By Application

• Biomarker Discovery
• Drug Discovery
• Toxicology Testing
• Nutrigenomics
• Functional Genomics
• Personalized Medicine
• Other Applications

By Indication

• Cancer
• Cardiovascular Disorders
• Neurological Disorders
• Inborn Errors of Metabolism
• Other Indications

COMPANIES PROFILED

• Thermo Fisher Scientific, Danaher, Agilent Technologies, Bruker, Shimadzu, Waters Corporation, QIAGEN, Revvity, Biocrates Life Sciences, Metabolon, Creative Proteomics, Nightingale Health, Human Metabolome Technologies, Chenomx, LECO, JEOL, SCIEX, Numares, OWL Metabolomics, Xcelris Labs

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL METABOLOMICS MARKET: BY PRODUCT AND SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product And Services
• 4.2. Metabolomics Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Metabolomics Bioinformatics Tools and Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL METABOLOMICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Biomarker Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Toxicology Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Nutrigenomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Functional Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Personalized Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL METABOLOMICS MARKET: BY INDICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Indication
• 6.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cardiovascular Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Neurological Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Inborn Errors of Metabolism Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Other Indications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL METABOLOMICS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product And Services
  • 7.2.2 By Application
  • 7.2.3 By Indication
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product And Services
  • 7.3.2 By Application
  • 7.3.3 By Indication
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Spain
  • 7.3.9 Russia
  • 7.3.10 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product And Services
  • 7.4.2 By Application
  • 7.4.3 By Indication
  • 7.4.4 China
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 India
  • 7.4.8 Australia
  • 7.4.9 South East Asia
  • 7.4.10 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product And Services
  • 7.5.2 By Application
  • 7.5.3 By Indication
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product And Services
  • 7.6.2 By Application
  • 7.6.3 By Indication
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL METABOLOMICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific
  • 9.2.2 Danaher
  • 9.2.3 Agilent Technologies
  • 9.2.4 Bruker
  • 9.2.5 Shimadzu
  • 9.2.6 Waters Corporation
  • 9.2.7 QIAGEN
  • 9.2.8 Revvity
  • 9.2.9 Biocrates Life Sciences
  • 9.2.10 Metabolon
  • 9.2.11 Creative Proteomics
  • 9.2.12 Nightingale Health
  • 9.2.13 Human Metabolome Technologies
  • 9.2.14 Chenomx
  • 9.2.15 LECO
  • 9.2.16 JEOL
  • 9.2.17 SCIEX
  • 9.2.18 Numares
  • 9.2.19 OWL Metabolomics
  • 9.2.20 Xcelris Labs